Metabolic syndrome and the risk of cardiovascular and all-cause mortality: data of 14-year prospective cohort study in Siberia

Abstract

Aim. To study the risk of cardiovascular and all-cause mortality in patients with metabolic syndrome (MS) according to a 14-year prospective cohort study in Siberia.Material and methods. Based on the data from the Russian arm of the HAPIEE project, we assessed all-cause deaths occurred by 2017 in the population cohort examined at baseline in 2003-2005 (n=9273). The baseline examination included the assessment of blood pressure (BP), anthropometry, levels of fasting triglycerides, high density lipoprotein cholesterol (HDL-C), and blood glucose. The fatal cases in the studied cohort were identified from “Medical death certificates” for the period from February 1, 2003 to December 31, 2017, based on data from the Department of Civil Registration of Death Acts. Cardiovascular death was established using the International Classification of Diseases, the 10th revision (ICD-10): I (0-99).Results. The mortality rate in subjects with MS was 16,6% — 751 deaths (25,1% in men and 11,5% in women), and it was 20-30% higher than in those without MS. Cardiovascular mortality in subjects with MS was 12,6% — 572 deaths (20,5% in men and 8,9% in women), and it was nearly 30% higher than in those without MS. Multivariable Cox regression revealed that among the components of MS, the elevated BP level even with BP ≥135/80 mm Hg had the major impact on increasing the risk of all-cause mortality (HR=1,7 (1,4; 2,1) in men; HR=2,2 (1,7; 2,8) in women) and increasing the risk of cardiovascular mortality (HR=2,2 (1,5; 3,0) in men and HR=2,8 (1,8; 4.3) in women). Among men, already 1 component of MS increased the risk of cardiovascular and all-cause mortality by 2,0 or more times; among women, 2-4 components of MS increased the risk of death by 3 times, and 5 components — by 4.Conclusion. In the studied population sample, cardiovascular and all-cause mortality during the 14-year follow-up in individuals with MS was about 25-30% higher compared to those without MS. The risk of cardiovascular and all-cause deaths in subjects with MS is comparable to the risk in case of blood pressure ≥135/80 mm Hg. With an increase in the number of MS components from 1 to 5, the risk of all-cause and cardiovascular death increases.

Obesity Prevalence and Associated Socio-Demographic Characteristics and Health Behaviors in Russia and Norway

“…Assessing AO is important because it is commonly combined with other components of metabolic syndrome [ 48 , 66 ] and is a stronger predictor of CVD and diabetes compared to GO [ 24 , 28 , 69 ]. WHR showed the strongest associations with overall and cardiovascular disease mortality compared to other AO indicators (WC or WHeR) [ 27 , 48 , 65 , 66 ].…”

Age-related trends of physical activity and work capacity among men and women in an open urban population

“…Популяционные закономерности, полученные для мужчин и женщин среднего возраста, также определяют особенности подхода при планировании профилактических мероприятий в этой возрастной категории. В условиях цивилизации современного мира, которую еще более усугубили реалии пандемии новой коронавирусной инфекции, снижение ФА стало одной из важнейших черт, повышающей риск общей и сердечно-сосудистой смерти [5,15]. При положительной тенденции к росту активного досуга среди мужчин среднего возраста имеет место снижение ФА и трудоспособности за последний год, несмотря на попытки к регулярным физическим упражнениям, значительно превышающие такое стремление у мужчин молодого возраста.…”

Clinical variants of the metabolic syndrome in young people living in the Khanty-Mansiysk autonomous region – Yugra

“…Составляющие МС являются факторами риска возникновения сердечно-сосудистых заболеваний, сахарного диабета и сопутствующих кардиоваскулярных осложнений [1,2]. Сочетание компонентов МС и увеличение их количества способствуют увеличению риска смертности от сердечно-сосудистых осложнений [3].…”